Page last updated: 2024-10-19

nitrates and Peripheral Vascular Diseases

nitrates has been researched along with Peripheral Vascular Diseases in 9 studies

Nitrates: Inorganic or organic salts and esters of nitric acid. These compounds contain the NO3- radical.

Peripheral Vascular Diseases: Pathological processes involving any one of the BLOOD VESSELS in the vasculature outside the HEART.

Research Excerpts

ExcerptRelevanceReference
"We investigated in this double-blind, controlled study whether prolonged intermittent infusion therapy with L-arginine improves the clinical symptoms of patients with intermittent claudication, as compared with the endothelium-independent vasodilator prostaglandin E1, and control patients."9.08Restoring vascular nitric oxide formation by L-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease. ( Alexander, K; Bode-Böger, SM; Böger, RH; Creutzig, A; Frölich, JC; Thiele, W, 1998)
"We explored the efficacy of intravenous therapy with propionyl L-carnitine in patients with both peripheral arterial disease (PAD) and chronic renal insufficiency requiring haemodialysis."5.12A randomised, controlled clinical trial evaluating changes in therapeutic efficacy and oxidative parameters after treatment with propionyl L-carnitine in patients with peripheral arterial disease requiring haemodialysis. ( Celotta, G; Di Pino, L; Fallico, R; Fatuzzo, P; Ferrante, M; Massimiliano, A; Neri, S; Oliveri Conti, G; Pennisi, G; Rapisarda, F; Signorelli, SS, 2006)
"We investigated in this double-blind, controlled study whether prolonged intermittent infusion therapy with L-arginine improves the clinical symptoms of patients with intermittent claudication, as compared with the endothelium-independent vasodilator prostaglandin E1, and control patients."5.08Restoring vascular nitric oxide formation by L-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease. ( Alexander, K; Bode-Böger, SM; Böger, RH; Creutzig, A; Frölich, JC; Thiele, W, 1998)

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19902 (22.22)18.7374
1990's3 (33.33)18.2507
2000's4 (44.44)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
POLETTI, RA1
ABRAMSON, DI1
de Berrazueta, JR1
Sampedro, I1
Garcia-Unzueta, MT1
Llorca, J1
Bustamante, M1
Amado, JA1
Yamada, K1
Suzuki, E1
Nakaki, T1
Watanabe, S1
Kanba, S1
Signorelli, SS1
Fatuzzo, P1
Rapisarda, F1
Neri, S1
Ferrante, M1
Oliveri Conti, G1
Fallico, R1
Di Pino, L1
Pennisi, G1
Celotta, G1
Massimiliano, A1
Loffredo, L1
Marcoccia, A1
Pignatelli, P1
Andreozzi, P1
Borgia, MC1
Cangemi, R1
Chiarotti, F1
Violi, F1
Böger, RH2
Bode-Böger, SM2
Thiele, W2
Junker, W1
Alexander, K2
Frölich, JC2
Creutzig, A1
Arosio, E1
Cuzzolin, L1
De Marchi, S1
Minuz, P1
Degan, M1
Crivellente, F1
Zannoni, M1
Benoni, G1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Effects of Trehalose and a Mix of Polyphenols on Endothelial Function, Oxidative Stress, Platelet Function and Autophagy in Vasculopathic Patients[NCT04061070]80 participants (Actual)Interventional2019-12-12Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

6 trials available for nitrates and Peripheral Vascular Diseases

ArticleYear
Effect of transdermal nitroglycerin on inflammatory mediators in patients with peripheral atherosclerotic vascular disease.
    American heart journal, 2003, Volume: 146, Issue:4

    Topics: Administration, Cutaneous; Adult; Aged; Anti-Inflammatory Agents; Arteriosclerosis; Biomarkers; C-Re

2003
Aconiti tuber increases plasma nitrite and nitrate levels in humans.
    Journal of ethnopharmacology, 2005, Jan-04, Volume: 96, Issue:1-2

    Topics: Aconitum; Adult; Aged; Chromatography, High Pressure Liquid; Drugs, Chinese Herbal; Female; Humans;

2005
A randomised, controlled clinical trial evaluating changes in therapeutic efficacy and oxidative parameters after treatment with propionyl L-carnitine in patients with peripheral arterial disease requiring haemodialysis.
    Drugs & aging, 2006, Volume: 23, Issue:3

    Topics: Aged; Aldehydes; Carnitine; Double-Blind Method; Humans; Malondialdehyde; Middle Aged; Nitrates; Nit

2006
Oxidative-stress-mediated arterial dysfunction in patients with peripheral arterial disease.
    European heart journal, 2007, Volume: 28, Issue:5

    Topics: 8-Hydroxy-2'-Deoxyguanosine; Adult; Aged; Aged, 80 and over; Analysis of Variance; Antioxidants; Bio

2007
Restoring vascular nitric oxide formation by L-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease.
    Journal of the American College of Cardiology, 1998, Volume: 32, Issue:5

    Topics: Aged; Aged, 80 and over; Alprostadil; Arginine; Arterial Occlusive Diseases; Blood Flow Velocity; Ch

1998
Increased endogenous nitric oxide production induced by physical exercise in peripheral arterial occlusive disease patients.
    Life sciences, 1999, Volume: 65, Issue:26

    Topics: Aged; Arterial Occlusive Diseases; Cell Adhesion; Exercise Therapy; Humans; Iloprost; Infusions, Int

1999

Other Studies

3 other studies available for nitrates and Peripheral Vascular Diseases

ArticleYear
[Treatment of coronary insufficiency, thromboangilitis & cerebral arteritis with intravenous sodium nitrate].
    El Dia medico, 1957, May-02, Volume: 29, Issue:26

    Topics: Arteritis; Brain; Coronary Disease; Humans; Nitrates; Nitrites; Peripheral Vascular Diseases; Thromb

1957
DRUGS USED IN PERIPHERAL VASCULAR DISEASES.
    The American journal of cardiology, 1963, Volume: 12

    Topics: Deoxyribonuclease I; Dihydroergotoxine; Endopeptidases; Ergot Alkaloids; Ganglionic Blockers; Histam

1963
Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease.
    Circulation, 1997, Apr-15, Volume: 95, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Aging; Arginine; Arterial Occlusive Diseases; Cyclic GMP; Disease Pr

1997